Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Clinical Research and Equipment Industry Analysis
UpdatedJan 30, 2026
DataAggregated Company Financials
Companies1
- 7D4.1%
- 3M8.6%
- 1Y50.7%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has risen 5.2%, driven by gains from every company within the industry. This means that the industry has gained 48% over the past year. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the Italian Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 30 Jan 2026 | €247.0m | €256.9m | €12.5m | 19.7x | 19.7x | 1x |
| Sun, 28 Dec 2025 | €231.8m | €256.9m | €12.5m | 18.5x | 18.5x | 0.9x |
| Tue, 25 Nov 2025 | €227.4m | €256.9m | €12.5m | 18.2x | 18.2x | 0.9x |
| Thu, 23 Oct 2025 | €226.9m | €250.3m | €12.4m | 18.2x | 18.2x | 0.9x |
| Sat, 20 Sep 2025 | €217.6m | €250.3m | €12.4m | 17.5x | 17.5x | 0.9x |
| Mon, 18 Aug 2025 | €214.2m | €250.3m | €12.4m | 17.2x | 17.2x | 0.9x |
| Wed, 16 Jul 2025 | €191.5m | €241.8m | €9.4m | 20.4x | 20.4x | 0.8x |
| Fri, 13 Jun 2025 | €188.5m | €241.8m | €9.4m | 20.1x | 20.1x | 0.8x |
| Sun, 11 May 2025 | €184.1m | €241.8m | €9.4m | 19.6x | 19.6x | 0.8x |
| Tue, 08 Apr 2025 | €165.0m | €244.4m | €8.2m | 20.2x | 20.2x | 0.7x |
| Thu, 06 Mar 2025 | €166.5m | €243.4m | €4.9m | 34.3x | 34.3x | 0.7x |
| Sat, 01 Feb 2025 | €166.5m | €243.4m | €4.9m | 34.3x | 34.3x | 0.7x |
| Mon, 30 Dec 2024 | €181.2m | €243.4m | €4.9m | 37.3x | 37.3x | 0.7x |
| Wed, 27 Nov 2024 | €194.4m | €243.4m | €4.9m | 40.1x | 40.1x | 0.8x |
| Fri, 25 Oct 2024 | €208.1m | €247.2m | €2.6m | 79.7x | 79.7x | 0.8x |
| Sun, 22 Sep 2024 | €201.2m | €246.6m | €2.6m | 77.1x | 77.1x | 0.8x |
| Tue, 20 Aug 2024 | €205.7m | €251.8m | -€3,610,645.00 | n/a | -57x | 0.8x |
| Thu, 18 Jul 2024 | €220.3m | €251.8m | -€3,610,645.00 | n/a | -61x | 0.9x |
| Sat, 15 Jun 2024 | €219.9m | €251.8m | -€3,610,645.00 | n/a | -60.9x | 0.9x |
| Mon, 13 May 2024 | €207.1m | €251.8m | -€3,522,098.00 | n/a | -58.8x | 0.8x |
| Wed, 10 Apr 2024 | €204.7m | €251.8m | -€3,522,098.00 | n/a | -58.1x | 0.8x |
| Fri, 08 Mar 2024 | €205.4m | €239.7m | €627.8k | 327.2x | 327.2x | 0.9x |
| Sun, 04 Feb 2024 | €219.5m | €239.7m | €627.8k | 349.6x | 349.6x | 0.9x |
| Tue, 02 Jan 2024 | €214.8m | €239.7m | €627.8k | 342.2x | 342.2x | 0.9x |
| Thu, 30 Nov 2023 | €192.3m | €239.7m | €627.8k | 306.4x | 306.4x | 0.8x |
| Sat, 28 Oct 2023 | €187.7m | €233.7m | -€5,128,619.00 | n/a | -36.6x | 0.8x |
| Mon, 25 Sep 2023 | €201.5m | €233.7m | -€5,128,619.00 | n/a | -39.3x | 0.9x |
| Wed, 23 Aug 2023 | €196.1m | €221.7m | -€4,112,756.00 | n/a | -47.7x | 0.9x |
| Fri, 21 Jul 2023 | €197.4m | €221.7m | -€4,112,756.00 | n/a | -48x | 0.9x |
| Sun, 18 Jun 2023 | €233.2m | €221.7m | -€4,112,756.00 | n/a | -56.7x | 1.1x |
| Tue, 16 May 2023 | €208.8m | €206.9m | -€9,501,145.00 | n/a | -22x | 1x |
| Thu, 13 Apr 2023 | €233.2m | €206.9m | -€9,501,145.00 | n/a | -24.5x | 1.1x |
| Sat, 11 Mar 2023 | €232.6m | €202.7m | -€10,427,495.00 | n/a | -22.3x | 1.1x |
| Mon, 06 Feb 2023 | €227.6m | €202.7m | -€10,427,495.00 | n/a | -21.8x | 1.1x |
Price to Earnings Ratio
-21.8x
Current Industry PE
- There is only one company in the Italian Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- Total earnings for the Life Sciences Tools and Services industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 8.2% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Italian Clinical Research and Equipment compare with similar industries?
| IT Market | -0.32% | |
| Healthcare | -0.89% | |
| Life Sciences | 4.12% | |
| Clinical Research and Equipment | 4.12% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| FF Fine Foods & Pharmaceuticals N.T.M | €10.10 | 4.1% +€9.8m | 50.7% | PE19.7x |